Evaluating thoracoscopic pleural biopsy for pleural diseases
Thoracoscopic Pleural Biopsy, Sohag University Hospital
This study tests how safe and effective a procedure called thoracoscopic pleural biopsy is for adults who might have pleural diseases.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 36 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06964308 on ClinicalTrials.gov |
What this trial studies
This study evaluates the diagnostic efficacy, safety, and clinical outcomes of thoracoscopic pleural biopsy in patients suspected of having pleural diseases. It involves adult patients who have been referred for this procedure after necessary preoperative evaluations. The study aims to determine how effective and safe this intervention is in managing pleural conditions.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with suspected pleural disease who require a thoracoscopic pleural biopsy.
Not a fit: Patients with contraindications to thoracoscopic biopsy or those who have already been definitively diagnosed with a condition that does not require this procedure may not benefit.
Why it matters
Potential benefit: If successful, this study could improve diagnostic accuracy and treatment outcomes for patients with pleural diseases.
How similar studies have performed: While specific data on similar studies is not provided, thoracoscopic biopsy is a recognized procedure in the management of pleural diseases, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with suspected pleural disease who have been referred for thoracoscopic pleural biopsy * Age: Adults aged 18 years and older * Patients should have undergone necessary preoperative evaluations, including imaging studies (e.g., chest X-ray, CT scan) that indicate a need for biopsy. Exclusion Criteria: * Contraindications to Thoracoscopic Biopsy: Patients with contraindications to thoracoscopic biopsy * Infeasibility of Procedure: Patients with anatomical or physiological factors that make thoracoscopic biopsy technically unfeasible or unsafe (e.g., severe pleural adhesions or distorted anatomy). * Alternative Diagnoses: Patients who have been definitively diagnosed with a condition that does not require thoracoscopic biopsy for further evaluation. * Pregnancy: Pregnant women may be excluded due to potential risks to the fetus and the need for specific procedural considerations. * Inability to Provide Consent: Patients who are unable to provide informed consent due to cognitive impairment, language barriers, or other reasons. * Participation in Concurrent Studies: Patients currently participating in other clinical studies that could interfere with the outcomes of this study or affect their eligibility.
Where this trial is running
Sohag
- Sohag University Hospital — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: Ahmed O Yehya, Resident
- Email: ahmedosamayehya37@yahoo.com
- Phone: 01146628670
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.